Concepedia

Delan Khalid

DK

Statistics

Publications

4

Citations

193

H-Index

4

Active since

2018

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Boston Children's Hospital

Howard Hughes Medical Institute

Delan Khalid is an author at Dana-Farber Cancer Institute specializing in medicine, tumor biology, and genetics.

ORCID

Top concepts

Publications per year

2018–2024

4

Publications

4

Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1

Nathaniel W. Mabe, Min Huang, Guillermo Nicolás Dalton et al. · Nature Cancer · 2022 · 100 citations · Full text

, , +6

Orexin 2 receptor stimulation enhances resilience, while orexin 2 inhibition promotes susceptibility, to social stress, anxiety and depression

Clarissa D. Staton, Jazmine D. W. Yaeger, Delan Khalid et al. · Neuropharmacology · 2018 · 66 citations · Full text

Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors

Clare F. Malone, Minjee Kim, Gabriela Alexe et al. · Cancer Research · 2022 · 15 citations · Full text

Inherent genome instability underlies trisomy 21-associated myeloid malignancies

Chun-Chin Chen, Rebecca E. Silberman, Duanduan Ma et al. · Leukemia · 2024 · 12 citations · Full text

, , +3

1–4 of 4